Quisinostat
| CAS No. | 875320-29-9 |
|---|---|
| MDL No. | MFCD17010272 |
| MF | C21H26N6O2 |
| MW | 394.50 |
| InChI Key | PAWIYAYFNXQGAP-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Quisinostat is a methylindole with a 1H-indole core substituted at positions 1 and 3 by methyl and [({1-[5-(hydroxycarbamoyl)pyrimidin-2-yl]piperidin-4-yl}methyl)amino]methyl groups, respectively. It is an orally bioavailable pan-HDAC inhibitor with antineoplastic activity. It functions as an antineoplastic agent, EC 3.5.1.98 (histone deacetylase) inhibitor, autophagy inducer, radiosensitizing agent, bone density conservation agent, and antimalarial. It is also a secondary amino compound, a piperidine, a pyrimidine, and a hydroxamic acid.
| CAS No. | 875320-29-9 |
|---|---|
| Product Name | Quisinostat |
Biological Targets
HDAC1·HDAC3·HDAC6·HDAC2·HDAC5·
Associated Conditions
Cutaneous T-cell lymphoma·ovarian cancer·lymphoma
* The information provided here is compiled from public sources and is for reference only.